Wyeth's Cordarone Adds Patient "MedGuide"
This article was originally published in The Pink Sheet Daily
Executive Summary
The anti-arrhythmic will be dispensed with a patient medication guide highlighting the risk of pulmonary toxicity, liver injury and exacerbation of arrhythmias. Copies of the MedGuide will be included in shipments of the drug for distribution by pharmacists.
You may also be interested in...
Wyeth Cordarone MedGuide To Be Co-Packaged
Pharmacists are being given 100 medication guides to distribute with the anti-arrhythmic as Wyeth develops new packaging.
Wyeth Cordarone MedGuide To Be Co-Packaged
Pharmacists are being given 100 medication guides to distribute with the anti-arrhythmic as Wyeth develops new packaging.
FDA To Face Congressional Scrutiny Over Cordarone “MedGuide”
The Senate Finance Committee is interested in FDA’s handling of risk information for Wyeth’s anti-arrhythmic. FDA and Wyeth say development of a patient “MedGuide” is near completion.